BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 11858519)

  • 1. Nanoparticle technology for drug delivery across the blood-brain barrier.
    Lockman PR; Mumper RJ; Khan MA; Allen DD
    Drug Dev Ind Pharm; 2002 Jan; 28(1):1-13. PubMed ID: 11858519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK
    Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges.
    Gidwani M; Singh AV
    Curr Pharm Biotechnol; 2014; 14(14):1201-12. PubMed ID: 24809717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct drug delivery to the brain].
    Chekhonin VP; Zhirkov IuA; Dmitrieva TB
    Vestn Ross Akad Med Nauk; 2006; (8):30-7. PubMed ID: 17002024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P; Khrestchatisky M
    Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; GrazĂș V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.
    Moura RP; Martins C; Pinto S; Sousa F; Sarmento B
    Expert Opin Drug Deliv; 2019 Mar; 16(3):271-285. PubMed ID: 30767695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
    Al-Ahmady ZS
    Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
    Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
    Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor Targeted Polymeric Nanostructures Capable of Navigating across the Blood-Brain Barrier for Effective Delivery of Neural Therapeutics.
    Dube T; Chibh S; Mishra J; Panda JJ
    ACS Chem Neurosci; 2017 Oct; 8(10):2105-2117. PubMed ID: 28768412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to improve drug delivery across the blood-brain barrier.
    de Boer AG; Gaillard PJ
    Clin Pharmacokinet; 2007; 46(7):553-76. PubMed ID: 17596102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances in delivery of biotherapeutics across the blood-brain barrier.
    Rajadhyaksha M; Boyden T; Liras J; El-Kattan A; Brodfuehrer J
    Curr Drug Discov Technol; 2011 Jun; 8(2):87-101. PubMed ID: 21513485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review.
    Ansari MA; Chung IM; Rajakumar G; Alzohairy MA; Alomary MN; Thiruvengadam M; Pottoo FH; Ahmad N
    Curr Pharm Des; 2020; 26(11):1128-1137. PubMed ID: 31951165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle technology for delivery of drugs across the blood-brain barrier.
    Schroeder U; Sommerfeld P; Ulrich S; Sabel BA
    J Pharm Sci; 1998 Nov; 87(11):1305-7. PubMed ID: 9811481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.